Published by
@ShahidNShah
@ShahidNShah
The 4th Annual Ligase Targeting Drug Development Summit, scheduled from May 7 to May 9, 2024, addresses challenges in developing mono- and bivalent degraders and harnessing the potential of E3 ligases. With a focus on discovering, validating, and utilizing novel E3 ligases, the summit aims to overcome obstacles in ligase screening, structural characterization, and assessing therapeutic efficacy. Bringing together over 80 ligase experts, the event features data-driven presentations, technical discussions, and interactive sessions. The Ligase Targeting Drug Development Summit serves as a collaborative platform to unlock therapeutic opportunities, advancing the field of drug development through insights and expertise.
[Read on ligase-drugdevelopment.com](https://ligase-drugdevelopment.com/take-part/register/)
Continue reading at ligase-drugdevelopment.com
May 7 to May 9, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am